Navigation Links
BellBrook Labs Awarded NIH Grant to Develop a High Throughput cGAS Assay for Cancer and Autoimmune Disease Drug Discovery
Date:6/14/2017

The National Institutes of General Medical Sciences (NGMS) has awarded a Phase I $288,000 Small Business Innovative Research (SBIR) grant to BellBrook Labs, LLC for the commercialization of an innovative high throughput screening (HTS) assay for detecting cyclic GMP-AMP(cGAMP) the product of the cGAMP synthase (cGAS) enzyme.

cGAS is a novel target shown to have implications in immuno-oncology and autoimmune diseases. As foreign DNA enters the cell, cGAS detects the DNA and produces cGAMP, which acts as an agonist for the STING (stimulator of interferon genes) receptor to induce a type I interferon response. Researchers have shown that regulating cGAS activity could help control this immune response with therapeutic benefit for interferon-driven autoimmune diseases such as lupus. Progress discovering small molecule cGAS modulators have been slowed by the lack of HTS-compatible assays.

BellBrook has leveraged its proprietary Transcreener® platform to directly measure cGAMP in a homogeneous immunoassay format with fluorescent readouts. Direct detection reduces the potential for interference in HTS and allows kinetic methods such as determination of residence times for more effective lead optimization early in discovery. The Transcreener cGAS Assay will enable screening of diverse small molecules for an emerging target in autoimmunity and immuno-oncology, accelerating discovery of first-in-class drugs for debilitating diseases.

About BellBrook Labs:

BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions. Transcreener® is a universal, homogeneous biochemical assay platform based on detection of nucleotides that makes it easy to screen thousands of different enzymes. These include validated targets like kinases and phosphodiesterases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. Detection reagents and drug discovery services from BellBrook Labs help researchers progress toward more effective therapies for cancer and other debilitating diseases.

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R43GM123833.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read the full story at http://www.prweb.com/releases/cGAS/Assay/prweb14421391.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. BellBrook Labs Webinar: Development of Ectonucleotidase Assay Methods Using the Transcreener® HTS Assay Platform
2. Top Accolades Awarded to Angry Citizen, Ecocat, Medesk and WESTUDY.IN At Challenge Cup Moscow
3. Puritan Medical Products Awarded Two New Flocked Swab Patents in Australia
4. Borrego Health Awarded $816,667 to Open Clinics in Anza and San Jacinto
5. Team of Chicago hospitals awarded grant to accelerate stroke research, treatments
6. Icahn School of Medicine at Mount Sinai awarded $2.7 million from NIH to investigate novel therapy for eczema
7. Steven Winter Associates, Inc. Awarded U.S. EPA's 2013 Indoor airPLUS Leader Award
8. Advanced Medical Awarded Recertification by the Joint Commission
9. Arminco, Inc. Awarded Contract to Design Alexandria Dental Office of Parker-Gray Pediatric Dental Care
10. Aequor Technologies Awarded Managed Services Contract to Provide Hardware Configuration and Deployment for Global Pharmaceutical Corporation
11. Kessler Foundation awarded grant to study self-generated learning in multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2018)... ... 2018 , ... The Colorado Rural Health Center (CRHC) is proud to recognize ... community during National Rural Health Day 2018. National Rural Health Day falls on the ... health needs of over 60 million people across the nation. , This year, ...
(Date:11/16/2018)... ... November 16, 2018 , ... Author ... Physician: How Science Transformed the Art of Medicine (GreenLeaf Press, 2018) was recently ... and medical. , Interweaving moving personal patient stories with a historical overview ...
(Date:11/16/2018)... ... November 16, 2018 , ... Hangover Heaven®, a hangover treatment ... antioxidants, has changed its name to Hangover Heaven IV Hydration® in an effort ... IV therapy and IV hydration through our hangover cures products, we wanted our ...
(Date:11/16/2018)... , ... November 16, 2018 , ... ... announced today a historic agreement with Taikang Healthcare in China to provide clinical ... Drum Tower Hospital in Nanjing, the capital of Jiangsu Province in east central ...
(Date:11/16/2018)... ... November 16, 2018 , ... OnlineMasters.com, an ... Educational Psychology Programs for 2019. They have identified the top programs in the ... affordability, and graduate outcomes. , Leveraging an exclusive data set comprised of interviews ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 15, 2018 , ... ... that the company has been awarded a $225,000 Phase I Small Business Innovation ... of Health (NIH). , The pursuit of useful, well-structured data gathered outside the ...
(Date:11/15/2018)... ... November 15, 2018 , ... ... Treatment Program (OTP) with locations in Salt Lake City and Ogden, Utah ... as a high-quality, trusted provider of evidence-based treatment for opioid addiction. The ...
(Date:11/15/2018)... ... 2018 , ... Willow Risk Advisors today announced a partnership ... program available to its members. In an effort to further increase value ... endorsed Willow Risk Advisors as their professional liability insurance broker. Teaming up ...
Breaking Medicine Technology: